Warning: This security is no longer trading.
defunct
Progenics Pharmaceuticals Inc. (PGNX): Price and Financial Metrics
PGNX Price/Volume Stats
| Current price | $4.10 | 52-week high | $6.37 |
| Prev. close | $4.53 | 52-week low | $1.89 |
| Day low | $3.94 | Volume | 34,928,300 |
| Day high | $4.79 | Avg. volume | 1,157,679 |
| 50-day MA | $4.05 | Dividend yield | N/A |
| 200-day MA | $4.61 | Market Cap | 355.05M |
PGNX Stock Price Chart Interactive Chart >
Progenics Pharmaceuticals Inc. (PGNX) Company Bio
Progenics Pharmaceuticals is developing innovative medicines for oncology, with a pipeline that includes several product candidates in later-stage clinical development. The company was founded in 1986 and is based in Tarrytown, New York.
PGNX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | -27.69% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | 0.00% |
| 2019 | 21.19% |
Continue Researching PGNX
Want to do more research on Progenics Pharmaceuticals Inc's stock and its price? Try the links below:Progenics Pharmaceuticals Inc (PGNX) Stock Price | Nasdaq
Progenics Pharmaceuticals Inc (PGNX) Stock Quote, History and News - Yahoo Finance
Progenics Pharmaceuticals Inc (PGNX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...